Montanaro, Anna
Kitara, Samuel
Cerretani, Elisa
Marchesini, Matteo
Rompietti, Chiara
Pagliaro, Luca
Gherli, Andrea
Su, Angela
Minchillo, Maria Laura
Caputi, Mariafrancesca
Fioretzaki, Rodanthi
Lorusso, Bruno
Ross, Linda
Alexe, Gabriela http://orcid.org/0000-0002-5668-6297
Masselli, Elena http://orcid.org/0000-0002-4765-0428
Marozzi, Marina
Rizzi, Federica Maria Angela
La Starza, Roberta
Mecucci, Cristina
Xiong, Yan
Jin, Jian http://orcid.org/0000-0002-2387-3862
Falco, Angela
Knoechel, Birgit
Aversa, Franco
Candini, Olivia
Quaini, Federico
Sportoletti, Paolo
Stegmaier, Kimberly
Roti, Giovanni
Article History
Received: 25 January 2022
Revised: 27 May 2022
Accepted: 7 June 2022
First Online: 17 June 2022
Competing interests
: KS receives grant funding from Novartis, previously consulted for Rigel Pharmaceuticals, AstraZeneca, KronosBio, and Auron Therapeutics, and has stock options with Auron Therapeutics, on work unrelated to this manuscript.